Former Elscint executive Robert Sohval has joined SmartLight,an Israeli technology firm that has developed a computer-controlledlight box designed to automatically mask glare from light usedto illuminate x-ray films (SCAN 1/31/96). Sohval has been
Former Elscint executive Robert Sohval has joined SmartLight,an Israeli technology firm that has developed a computer-controlledlight box designed to automatically mask glare from light usedto illuminate x-ray films (SCAN 1/31/96). Sohval has been namedpresident and CEO of SmartLight's U.S. subsidiary, based in Hackensack,NJ.
Sohval left Elscint in 1994 for TransScan Medical, a development-stagecompany working on breast-imaging technology using electricalimpedance rather than x-rays. At SmartLight, one of Sohval's firstduties is to build a sales and marketing organization to sellthe company's SmartLight 2000 Plus and SmartLight 4000 Plus systems.
SmartLight has placed the systems at beta sites and expectsto begin commercial shipments in the fourth quarter of this year,Sohval said.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.